צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים: Nephros Inc (NEPH)

Nephros, Inc. (NEPH) has become the benchmark for ultrafiltration in US clinics, providing unparalleled protection against infections. Stable demand for medical water purification makes the business crisis-resistant, although mass membrane production is fully outsourced. The quarterly EPS trajectory confirms these fundamentals, with the figure standing at 50.10, helping investors assess the regularity of the company's cash flows.

For an investor in Nephros, Inc. (NEPH), which develops high-precision ultrafiltration systems for dialysis, this indicator serves as a benchmark for the effectiveness of monetizing medical innovations. By analyzing the quarterly EPS growth rate through a comparison of current earnings per share with the previous period, one can assess the business scalability and the quality of capital management within the critical water purification segment.